Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Development of small molecule miR-17-92 inhibitors [miRNA-Seq]

ABSTRACT: MicroRNAs (miRNAs) are conserved small non-coding RNAs that regulate gene expression at the posttranscriptional level by pairing to the 3’ UTR of other genes. miR-17-92 is a key regulator of lymphocyte biology, controlling e.g. cell proliferation, survival as well as differentiation and function of different T cell subsets. miR-17-92 is amplified in human lymphomas and other malignancies and is also involved in additional disorders including immune, cardiovascular and neurodegenerative diseases as well as in aging. Given the importance of miR-17-92 in such a variety of diseases we aim at exploiting it as a therapeutic target. miRNAs can be inhibited through the administration of nucleotide-based inhibitors. Major disadvantages are their transient effect, instability and poor in vivo delivery. In contrast, small molecules permeate cells easily, are intracellularly stable and large libraries are available for high-throughput screening. We screened 60’000 compounds using a luciferase reporter assay and identified small molecules which modulate miR-17 reporter activity. Treatment of mouse naïve CD4 or CD8 T cells with one of the hit compounds resulted in similar phenotypes as in miR-17-92 deficient mice (different target derepression and reduced in vitro T cell differentiation). Screening of 172 chemically related compounds identified 2 analogs with improved potency. Treatment of primary human CD4 or CD8 cells as well as different tumor cell lines overexpressing the miR-17-92 cluster resulted in reduced proliferation and activation and increased cell death.

ORGANISM(S): Mus musculus

PROVIDER: GSE203633 | GEO | 2026/05/21

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Development of small molecule miR-17-92 inhibitors [RNA-Seq]

Project description:MicroRNAs (miRNAs) are conserved small non-coding RNAs that regulate gene expression at the posttranscriptional level by pairing to the 3’ UTR of other genes. miR-17-92 is a key regulator of lymphocyte biology, controlling e.g. cell proliferation, survival as well as differentiation and function of different T cell subsets. miR-17-92 is amplified in human lymphomas and other malignancies and is also involved in additional disorders including immune, cardiovascular and neurodegenerative diseases as well as in aging. Given the importance of miR-17-92 in such a variety of diseases we aim at exploiting it as a therapeutic target. miRNAs can be inhibited through the administration of nucleotide-based inhibitors. Major disadvantages are their transient effect, instability and poor in vivo delivery. In contrast, small molecules permeate cells easily, are intracellularly stable and large libraries are available for high-throughput screening. We screened 60’000 compounds using a luciferase reporter assay and identified small molecules which modulate miR-17 reporter activity. Treatment of mouse naïve CD4 or CD8 T cells with one of the hit compounds resulted in similar phenotypes as in miR-17-92 deficient mice (different target derepression and reduced in vitro T cell differentiation). Screening of 172 chemically related compounds identified 2 analogs with improved potency. Treatment of primary human CD4 or CD8 cells as well as different tumor cell lines overexpressing the miR-17-92 cluster resulted in reduced proliferation and activation and increased cell death.

2026-05-21 | GSE203620 | GEO

The transcription factor TAL1 and the miR-17-92 cluster establish a regulatory loop

Project description:A network of gene regulatory factors such as transcription factors and microRNAs establish and maintain the gene expression pattern during hematopoiesis. In this network transcription factors regulate each other and are involved in regulatory loops with microRNAs.The microRNA cluster miR-17-92 is located within the MIR17HG gene and encodes for six mature microRNAs. It is important for hematopoietic differentiation and plays a central role in malignant disease. However, the transcription factors downstream of miR-17-92 are largely elusive and the transcriptional regulation of miR-17-92 is not fully understood. Here we show that miR-17-92 forms a regulatory loop with the transcription factor TAL1. The miR-17-92 cluster inhibits expression of TAL1 and indirectly leads to decreased stability of the TAL1 transcriptional complex. We found that TAL1 and its heterodimerization partner E47 regulate miR-17-92 transcriptionally. Furthermore, miR-17-92 negatively influences erythroid differentiation, a process that depends on gene activation by the TAL1 complex. Our data give example of how transcription factor activity is fine-tuned during normal hematopoiesis. We postulate that disturbance of the regulatory loop between TAL1 and the miR-17-92 cluster could be an important step in cancer development and progression.

2021-09-09 | PXD018052 | Pride

The miR-17~92 family miRNAs regulate non-canonical NFκB pathway by targeting Socs3 to control plasma cell differentiation

Project description:Germinal center (GC) reaction in the lymphoid organs is a pivotal process for humoral immune response. The miR-17~92 family miRNAs have been demonstrated that regulate TFH cell differentiation, GC reaction and antibody response. However, whether they may also have functions in B cell activation and differentiation in GC reaction remain largely unknown. Here we show that mice with deletion of miR-17~92 in B cells exhibited reduced GC B cell formation and profound impaired plasma cell (PC) differentiation as well as decreased antibody response upon protein antigen immunization or chronic LMCV infection. In an in vitro plasma cell differentiation (iGCB) system, we found that miR-17~92 deficiency results in markedly decreased in vitro plasma cell (iPC) differentiation and defective NFB activation. Moreover, we developed and performed a screen by CRISPR/small guide (sg) RNA-mediated gene editing among the target genes of miR-17~92 in iGCB culture system. Intriguingly, Socs3 deletion substantially restored iPC differentiation and NFB activation in miR-17~92 deficient B cells, suggesting that Socs3 acts as a negative regulator of NFκB pathway involved in the regulation of iPC differentiation by miR-17~92. However, IL-21-induced STAT3 activation was not affected by miR-17~92 deficiency during iPC differentiation. Mechanistically, Socs3 interacts with MAP3K14 (NIK) and that promotes the ubiquitination of NIK and subsequent proteasome-mediated degradation of NIK, thereby leading to inhibition of the processing of p100 in non-canonical NFκB pathway and PC differentiation.

2023-09-27 | GSE208343 | GEO

miR-17-92/106b regulate beta cell mitotic checkpoint and insulin secretion

Project description:Adult beta cells in the pancreas are the sole source of insulin in our body. Beta cell loss or increased demand for insulin, impose metabolic challenges because adult beta cells are generally quiescent and infrequently re-enter the cell division cycle. miR-17-92/106b is a family of proto-oncogene microRNAs, that regulate proliferation in normal tissues and in cancer. Here, we employ mouse genetics to demonstrate a critical role for miR-17-92/106b in glucose homeostasis and in controlling insulin secretion. Mass spectrometry analysis was performed on miR-17-92LoxP/LoxP;106-25-/- MEF lysate, without or with CRE-Adenovirus. miR-17-92LoxP/LoxP;106-25+/+ MEFs with GFP-Adenovirus served as controls. We demonstrate that miR-17-92/106b regulate the adult beta cell mitotic checkpoint and that miR-17-92/106b deficiency results in reduction in beta cell mass in-vivo. Furthermore, protein kinase A (PKA) is a new relevant molecular pathway downstream of miR-17-92/106b in control of adult beta cell division and glucose homeostasis. Therefore, contributes to the understanding of proto-oncogene miRNAs in the normal, untransformed endocrine pancreas, and illustrates new genetic means for regulation of beta cell mitosis and function by non-coding RNAs.

2019-06-17 | PXD012610 | Pride

Complete male-to-female sex reversal in mice lacking the miR-17~92 cluster [RNA-seq]

Project description:The deletion of a single miRNA cluster, miR-17~92, is sufficient to induce primary sex reversal in XY mice. The expression of the testis determining gene, Sry, is delayed in embryonic XY miR-17~92 knockout gonads, which immediately activate the ovarian genetic program. Single cell RNA-seq analysis shows that Sertoli cell differentiation is highly reduced, delayed and unable to trigger testis differentiation. Consistent with the well-known role of miRNAs in gene regulation, the expression of target genes of miR-17~92 is not stabilized in XY mutant gonads at E11.5, affecting, in turn, the fine regulation of large gene networks involved in mammalian sex determination. Our results reveal that the miR-17~92 cluster is a novel sex-determining factor that modulates several gene networks required for accurate timing of Sry expression and Sertoli cell differentiation during testis determination and early differentiation. bulk RNA-seq, single cell RNA-seq as well as IF and other characterizations of a transgenic mice for miR-17~92 cluster

2023-07-09 | GSE225675 | GEO

miRNA expression in E18.5 murine total lung tissue

Project description:Knockout of the ubiquitously expressed microRNA-17~92 cluster in mice produces a lethal developmental lung defect. We validated the equally widely expressed pro-apoptotic Bim gene as joint target of miR-17~92 cluster members. To study the contribution of miR-17~92:Bim interaction to miR-17~92 overall function, we set up a system of conditional mutagenesis of the Bim 3’UTR. Blocking miR-17~92:Bim interaction early in development phenocopied the lethal lung phenotype of miR-17~92 ablation. Thus, despite hundreds of overall predicted targets vital miRNA functions can be mediated by a single target gene.

2019-11-10 | GSE123671 | GEO

The role of microRNA miR-17-92 in MYC oncogene addiction

Project description:miR-17-92 mediates the MYC oncogene addiction in a conditional mouse lymphoma model. To identify targets of miR-17-92 in this model, miR-17-92 was expressed in the conditional lymphoma cell lines using MSCV-puro.

2014-05-29 | GSE57507 | GEO

Oncogenic biogenesis of pri-miR-17~92

Project description:The microRNAs encoded by the miR-17~92 polycistron are commonly overexpressed in cancer and orchestrate a wide range of oncogenic functions. Here, we identify a novel mechanism for miR-17~92 oncogenic function through the disruption of endogenous miRNA processing. We show that upon oncogenic overexpression of the miR-17~92 primary transcript (pri-miR-17~92), the Microprocessor complex remains associated with partially processed intermediates that aberrantly accumulate. These intermediates reflect a series of hierarchical and conserved steps in the early processing of the pri-miR-17~92 transcript. Encumbrance of the Microprocessor by miR-17~92 intermediates leads to the broad, but selective, downregulation of co-expressed polycistronic miRNAs, including miRNAs derived from tumour suppressive miR-34b/c, and from the Dlk1-Dio3 polycistrons. We propose that the newly identified steps of polycistronic miR-17~92 biogenesis contribute to the oncogenic re-wiring of gene regulation networks. Our results reveal new functional paradigms for polycistronic miRNAs in cancer.

2019-05-20 | GSE130282 | GEO

Analysis of mir-17~92 targets in motor neurons

Project description:To identify mir-17~92 targets in MNs, a set of target candidate genes from the intersection of upregulated genes found only in the mir-17~92 KO MNs that were predicted to be direct targets of mir-17~92 by TargetScan.

2015-04-14 | GSE67795 | GEO

Ago2 PAR-CLIP analysis of Abelson kinase transformed murine B cell progenitors

Project description:Knockout of the ubiquitously expressed microRNA-17~92 cluster in mice produces a lethal developmental defect and blocked B lymphopoiesis. We validated the equally widely expressed Bcl2l11 gene as joint target of miR-17~92 cluster members. Bcl2l11 encodes the pro-apoptotic protein BIM, central to life-death decisions in most mammalian cells. To study the contribution of miR-17~92:Bim interaction to miR-17~92 overall function, we set up a system of conditional mutagenesis of the Bim 3’UTR in mice. Ago2 Photoactivatable-Ribonucleoside Cross-linking and Immunoprecipitation (AGO2 PAR-CLIP) allowed us to assess whether the seed match mutations introduced into the Bim 3’UTR in vivo indeed precluded interaction with the miRNAs of the 17~92 cluster. This analysis was done in Abelson Virus transformed B cell progenitors which we generated from wild type and Bim3’UTRmut/mut E14.5 fetal livers, knowing that these cells express both BIM and miR-17~92, can be expanded to large numbers and incorporate 4-thiouridine sufficiently well. Focusing on 21 nt windows around the 9 putative miR-17~92 seed matches in the Bim 3’UTR and excluding reads lacking T-to-C transitions, we we verified that the introduced mutationsare functional, and we discovered differential seed match coverage in the wild type, with one miR-19 seed match co-dominating with two miR-92 seed matches, while in the mutant 3’UTR miR-17~92 binding was completely abolished. These results demonstrate functionality and efficiency of our genetically engineered mouse model for in vivo conditional seed-match inactivation. These results demonstrate functionality and efficiency of our genetically engineered mouse model for in vivo conditional seed-match inactivation.

2019-11-13 | GSE124605 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data